You may experience side effects from tirzepatide (Mounjaro, Zepbound). One of the most common is nausea. In this video, learn tips to prevent or lessen nausea while taking tirzepatide to improve your treatment experience.
References
Borner, T., et al. (2022). Glucagon‐like peptide‐1 in diabetes care: Can glycaemic control be achieved without nausea and vomiting? British Journal of Pharmacology.
Eli Lilly and Company. (2023). Mounjaro - tirzepatide injection, solution [package insert].
Eli Lilly and Company. (2023). Zepbound - tirzepatide injection, solution [package insert].
MedlinePlus. (2022). When you have nausea and vomiting.
Wharton, S., et al. (2021). Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: Recommendations for clinical practice. Postgraduate Medicine.
Why trust our experts?


Search and compare options











